Skip to main content

Competitive displacement of phosphoinositide 3-kinase from beta-adrenergic receptor kinase-1 improves postinfarction adverse myocardial remodeling.

Publication ,  Journal Article
Curcio, A; Noma, T; Naga Prasad, SV; Wolf, MJ; Lemaire, A; Perrino, C; Mao, L; Rockman, HA
Published in: Am J Physiol Heart Circ Physiol
October 2006

Adverse remodeling after myocardial infarction (MI) determines the progression of heart failure. Failing hearts are characterized by downregulation of beta-adrenergic receptor (beta-AR) signaling in part because of increased beta-AR kinase 1 activity. Our previous studies have shown that overexpression of the phosphoinositide kinase (PIK) domain of phosphoinositide 3-kinase (PI3K), prevents beta-AR downregulation and enhances adrenergic agonist responsiveness by inhibiting the targeting of PI3K to the beta-AR complex. To investigate whether preventing beta-AR downregulation in the heart ameliorates cardiac function post-MI, transgenic mice with cardiac-specific overexpression of the PIK domain peptide (TgPIK) underwent left coronary artery ligation and were subsequently followed by serial echocardiography at 4, 8, 12, 16, and 20 wk. Despite having similar infarction sizes, TgPIK mice showed better systolic function, less cardiac dilatation, and improved hemodynamic response to dobutamine compared with littermate controls after MI. To test that displacement of PI3K from the beta-AR complex, but not the total loss of PI3K-gamma, is critical for amelioration of cardiac function, mice lacking the PI3K-gamma (PI3K-gamma-KO) underwent MI, and their cardiac function was assessed 20 wk post-MI. Serial echocardiographic measurements showed severe reduction in contractile performance in PI3K-gamma-KO compared with TgPIK mice. Furthermore, significant beta-AR downregulation and desensitization were only seen in infarcted wild-type and PI3K-gamma-KO mice and not in TgPIK mice. Together, these results demonstrate that adverse remodeling of the ventricle after MI can be attenuated by a strategy that prevents recruitment of PI3K to the plasma membrane and restores normal beta-AR function.

Duke Scholars

Published In

Am J Physiol Heart Circ Physiol

DOI

ISSN

0363-6135

Publication Date

October 2006

Volume

291

Issue

4

Start / End Page

H1754 / H1760

Location

United States

Related Subject Headings

  • beta-Adrenergic Receptor Kinases
  • Ventricular Remodeling
  • Ventricular Dysfunction, Left
  • Phosphatidylinositol 3-Kinases
  • Myocardial Infarction
  • Mice, Transgenic
  • Mice, Knockout
  • Mice
  • Male
  • Gene Expression Regulation
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Curcio, A., Noma, T., Naga Prasad, S. V., Wolf, M. J., Lemaire, A., Perrino, C., … Rockman, H. A. (2006). Competitive displacement of phosphoinositide 3-kinase from beta-adrenergic receptor kinase-1 improves postinfarction adverse myocardial remodeling. Am J Physiol Heart Circ Physiol, 291(4), H1754–H1760. https://doi.org/10.1152/ajpheart.01199.2005
Curcio, Antonio, Takahisa Noma, Sathyamangla V. Naga Prasad, Matthew J. Wolf, Anthony Lemaire, Cinzia Perrino, Lan Mao, and Howard A. Rockman. “Competitive displacement of phosphoinositide 3-kinase from beta-adrenergic receptor kinase-1 improves postinfarction adverse myocardial remodeling.Am J Physiol Heart Circ Physiol 291, no. 4 (October 2006): H1754–60. https://doi.org/10.1152/ajpheart.01199.2005.
Curcio A, Noma T, Naga Prasad SV, Wolf MJ, Lemaire A, Perrino C, et al. Competitive displacement of phosphoinositide 3-kinase from beta-adrenergic receptor kinase-1 improves postinfarction adverse myocardial remodeling. Am J Physiol Heart Circ Physiol. 2006 Oct;291(4):H1754–60.
Curcio, Antonio, et al. “Competitive displacement of phosphoinositide 3-kinase from beta-adrenergic receptor kinase-1 improves postinfarction adverse myocardial remodeling.Am J Physiol Heart Circ Physiol, vol. 291, no. 4, Oct. 2006, pp. H1754–60. Pubmed, doi:10.1152/ajpheart.01199.2005.
Curcio A, Noma T, Naga Prasad SV, Wolf MJ, Lemaire A, Perrino C, Mao L, Rockman HA. Competitive displacement of phosphoinositide 3-kinase from beta-adrenergic receptor kinase-1 improves postinfarction adverse myocardial remodeling. Am J Physiol Heart Circ Physiol. 2006 Oct;291(4):H1754–H1760.

Published In

Am J Physiol Heart Circ Physiol

DOI

ISSN

0363-6135

Publication Date

October 2006

Volume

291

Issue

4

Start / End Page

H1754 / H1760

Location

United States

Related Subject Headings

  • beta-Adrenergic Receptor Kinases
  • Ventricular Remodeling
  • Ventricular Dysfunction, Left
  • Phosphatidylinositol 3-Kinases
  • Myocardial Infarction
  • Mice, Transgenic
  • Mice, Knockout
  • Mice
  • Male
  • Gene Expression Regulation